Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab. - Gebrael G; Jo Y; Ozay ZI; Nandakumar V; Cigliola A; Tateo V; Lin E; Ostrowski M; Sayegh N; Murdock E; Mathew Thomas V; Gupta S; et al. (Bladder cancer (Amsterdam, Netherlands), 2026)